NO913683D0 - Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. - Google Patents
Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.Info
- Publication number
- NO913683D0 NO913683D0 NO913683A NO913683A NO913683D0 NO 913683 D0 NO913683 D0 NO 913683D0 NO 913683 A NO913683 A NO 913683A NO 913683 A NO913683 A NO 913683A NO 913683 D0 NO913683 D0 NO 913683D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- inhibitors
- procedure
- calcium
- recording
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/207—Unsaturated compounds containing keto groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/76—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
- C07C49/796—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Cosmetics (AREA)
- Steroid Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58575990A | 1990-09-20 | 1990-09-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO913683D0 true NO913683D0 (no) | 1991-09-19 |
NO913683L NO913683L (no) | 1992-03-23 |
Family
ID=24342836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91913683A NO913683L (no) | 1990-09-20 | 1991-09-19 | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0476658B1 (no) |
JP (1) | JP3296836B2 (no) |
KR (1) | KR100217806B1 (no) |
CN (1) | CN1059901A (no) |
AT (1) | ATE130289T1 (no) |
AU (1) | AU635156B2 (no) |
CA (1) | CA2051501C (no) |
DE (1) | DE69114635T2 (no) |
ES (1) | ES2082074T3 (no) |
FI (1) | FI914408A (no) |
HU (1) | HUT59076A (no) |
IE (1) | IE913298A1 (no) |
IL (1) | IL99511A0 (no) |
NO (1) | NO913683L (no) |
NZ (1) | NZ239865A (no) |
PT (1) | PT99012A (no) |
ZA (1) | ZA917369B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2131024A1 (en) * | 1992-03-06 | 1993-09-16 | Arsalan Kharazmi | Treatment and prophylaxis of diseases caused by parasites, or bacteria |
TW312688B (no) * | 1993-08-02 | 1997-08-11 | Mitsubishi Chem Corp | |
FR2713635B1 (fr) * | 1993-12-15 | 1996-01-05 | Cird Galderma | Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
IL162533A0 (en) | 2001-12-19 | 2005-11-20 | Atherogenics Inc | Chalcone derivatives and their use to treat diseases |
US7202247B2 (en) | 2001-12-19 | 2007-04-10 | Atherogenics, Inc. | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
EP2285421B1 (en) | 2008-05-02 | 2018-04-11 | Novadaq Technologies ULC | Methods for production and use of substance-loaded erythrocytes for observation and treatment of microvascular hemodynamics |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1111338A (en) * | 1964-07-24 | 1968-04-24 | Fisons Pharmaceuticals Ltd | Aralkyl substituted resorcinols |
BE758735A (fr) * | 1969-11-14 | 1971-05-10 | Hoffmann La Roche | Composes acetyleniques |
CA1137082A (en) * | 1979-05-23 | 1982-12-07 | Isao Umeda | Substituted acetophenones and process therefor |
JPS6385526A (ja) * | 1986-09-30 | 1988-04-16 | Nippon Oil & Fats Co Ltd | 非線形光学材料 |
JPH0669386B2 (ja) * | 1987-03-18 | 1994-09-07 | 協和醗酵工業株式会社 | 5′−イノシン酸の製造法 |
US4753965A (en) * | 1987-04-09 | 1988-06-28 | Merrell Dow Pharmaceuticals, Inc. | Method of treating multiple sclerosis with chalcone derivatives |
-
1991
- 1991-09-16 ZA ZA917369A patent/ZA917369B/xx unknown
- 1991-09-16 AU AU84528/91A patent/AU635156B2/en not_active Ceased
- 1991-09-16 CA CA002051501A patent/CA2051501C/en not_active Expired - Lifetime
- 1991-09-17 IL IL99511A patent/IL99511A0/xx unknown
- 1991-09-18 CN CN91109006A patent/CN1059901A/zh active Pending
- 1991-09-19 NO NO91913683A patent/NO913683L/no unknown
- 1991-09-19 NZ NZ239865A patent/NZ239865A/en unknown
- 1991-09-19 AT AT91115958T patent/ATE130289T1/de not_active IP Right Cessation
- 1991-09-19 ES ES91115958T patent/ES2082074T3/es not_active Expired - Lifetime
- 1991-09-19 FI FI914408A patent/FI914408A/fi unknown
- 1991-09-19 EP EP91115958A patent/EP0476658B1/en not_active Expired - Lifetime
- 1991-09-19 PT PT99012A patent/PT99012A/pt not_active Application Discontinuation
- 1991-09-19 IE IE329891A patent/IE913298A1/en unknown
- 1991-09-19 DE DE69114635T patent/DE69114635T2/de not_active Expired - Lifetime
- 1991-09-19 HU HU913011A patent/HUT59076A/hu unknown
- 1991-09-20 JP JP26850991A patent/JP3296836B2/ja not_active Expired - Lifetime
- 1991-09-20 KR KR1019910016529A patent/KR100217806B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP3296836B2 (ja) | 2002-07-02 |
PT99012A (pt) | 1992-08-31 |
NO913683L (no) | 1992-03-23 |
KR920006277A (ko) | 1992-04-27 |
KR100217806B1 (ko) | 1999-09-01 |
FI914408A0 (fi) | 1991-09-19 |
EP0476658A1 (en) | 1992-03-25 |
CA2051501C (en) | 2004-02-17 |
FI914408A (fi) | 1992-03-21 |
AU635156B2 (en) | 1993-03-11 |
NZ239865A (en) | 1993-12-23 |
HU913011D0 (en) | 1992-01-28 |
AU8452891A (en) | 1992-03-26 |
EP0476658B1 (en) | 1995-11-15 |
ATE130289T1 (de) | 1995-12-15 |
IL99511A0 (en) | 1992-08-18 |
CA2051501A1 (en) | 1992-03-21 |
DE69114635T2 (de) | 1996-04-18 |
ES2082074T3 (es) | 1996-03-16 |
IE913298A1 (en) | 1992-02-25 |
DE69114635D1 (de) | 1995-12-21 |
JPH0725812A (ja) | 1995-01-27 |
CN1059901A (zh) | 1992-04-01 |
HUT59076A (en) | 1992-04-28 |
ZA917369B (en) | 1992-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO913684L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
ES8105283A1 (es) | Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas | |
AU578050B2 (en) | Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them | |
ATE2271T1 (de) | 4-(substituierte thiazolyl)-3-hydroxy-3-pyrrolin2,5-dion-verbindungen, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung. | |
SE8600658D0 (sv) | Novel composition of matter | |
NO913683D0 (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
NO913685L (no) | Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer. | |
EP0316639A3 (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
ATE175349T1 (de) | Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie |